{"disease":{"id":"thrombocytopenia-immune","name":"thrombocytopenia immune"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05937828","title":"OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia","phase":"","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT00415532","title":"Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":234,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT07175493","title":"A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":158,"lead_sponsor_name":"Keymed Biosciences Co.Ltd","has_results":false},{"nct_id":"NCT06665308","title":"Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)","phase":"","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT03576742","title":"Severe Immune Cytopenia Registry Www.Sic-reg.Org","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Medical University of Graz","has_results":false},{"nct_id":"NCT01071954","title":"A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT07039422","title":"Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT07455006","title":"Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Qilu Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06533098","title":"A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT06449651","title":"A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":39,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT06444477","title":"Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT06523088","title":"A Study of PN20 in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Chongqing Peg-Bio Biopharm Co., Ltd.","has_results":false},{"nct_id":"NCT05785819","title":"A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":24,"lead_sponsor_name":"Veralox Therapeutics","has_results":false},{"nct_id":"NCT06888960","title":"Safety Study of CC312 in Autoimmune Disease Patients","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"CytoCares Inc","has_results":false},{"nct_id":"NCT06534021","title":"IASO-782 in Autoimmune Hematological Diseases","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":16,"lead_sponsor_name":"Shanghai IASO Biotechnology Co., Ltd","has_results":false},{"nct_id":"NCT02298933","title":"Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":true},{"nct_id":"NCT06337474","title":"An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":9,"lead_sponsor_name":"Changzhou No.2 People's Hospital","has_results":false},{"nct_id":"NCT03965624","title":"Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}